Oramed Pharmaceuticals Inc banner

Oramed Pharmaceuticals Inc
F:OJU1

Watchlist Manager
Oramed Pharmaceuticals Inc Logo
Oramed Pharmaceuticals Inc
F:OJU1
Watchlist
Price: 3.855 EUR 0.13% Market Closed
Market Cap: €156.2m

Wall St Price Targets

OJU1 Price Forecast
Based on 3 analysts

-18% Downside
from €3.855 today

Oramed Pharmaceuticals Inc (OJU1)’s 12-month stock price forecast through October 2027 has a consensus target of €3.145, implying 18% downside. The forecast is based on price targets from 3 Wall Street analysts.

OJU1 Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for OJU1 yet.

Oramed Pharmaceuticals Inc Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is OJU1's stock price target?
Price Target
3.145 EUR

According to Wall Street analysts, the average 1-year price target for OJU1 is 3.145 EUR with a low forecast of 3.115 EUR and a high forecast of 3.238 EUR.

What is the Pre-Tax Income forecast for Oramed Pharmaceuticals Inc?
Projected CAGR
236%

The compound annual growth rate for Pre-Tax Income over the next 1 year is 236%.

What is the Net Income forecast for Oramed Pharmaceuticals Inc?
Projected CAGR
200%

The compound annual growth rate for Net Income over the next 1 year is 200%.

Back to Top